Enhanced Vancomycin Hemodialysis model now available in DoseMeRx!Learn more →

News & Media

DoseMe Joins Microsoft for Healthcare Digital Innovation HISA Breakfast Series

In this article:

DoseMe Chief Executive Officer, Charles Cornish will join DoseMe advisor member and Microsoft’s global Chief Medical Officer, Dr Simon Kos alongside Dani Arousi from Allscripts’ to discuss digital health innovation at the upcoming HISA breakfast series in partnership with Microsoft.

Charles will discuss how DoseMe – the first company in the world to develop precision dosing software designed for clinical use – is reshaping the way medicine is dosed. He will share insights on how precision dosing algorithms and machine learning, coupled with SMART-on-FHIR, can significantly improve dosing accuracy and patient outcomes, by providing real-time decision support to enable precision medicine using readily available patient data.

Discussing the emerging trends in medical and health innovation, Dr Kos will focus on the use of technologies such as artificial (AI), chat and medical internet of things (loT).

The series is dedicated to highlighting how digital health innovation is advancing healthcare both in Australia and globally by helping to improve patient outcomes and reducing healthcare costs.

A new era in healthcare – opportunities fuelled by healthcare digital innovation
HISA breakfast series November 2017

Register to attend the Melbourne or Brisbane breakfast series:

Melbourne | November 10, 2017 | 7am

Brisbane | November 16, 2017 | 7am

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.